METTLER TOLEDO INC (MTD)

Sector: Health Care

    Home/Companies/MTD/Annual Meeting

2026 Annual Meeting Analysis

METTLER TOLEDO INC · Meeting: May 7, 2026

Policy v1.2high confidenceView Filing ↗
For informational purposes only. This AI-generated analysis applies a published voting policy to publicly available proxy filings. It does not constitute investment advice, proxy voting advice, or a solicitation of any kind. AI analysis may be incomplete or inaccurate — always review the actual filing and make your own independent decision.

Directors FOR

8

Directors AGAINST

1

Say on Pay

FOR

Auditor

FOR

Director Elections

Election of Directors

8 FOR/1 AGAINST

Against Analysis

✗ AGAINST
Roland Diggelmann3-year TSR underperformance trigger: MTD -18.1% vs peer median +3.6%, gap of -21.7pp exceeds 20pp threshold for negative absolute TSR; 5-year TSR does not cure: MTD +6.5% vs peer median +9.9%, gap of -3.4pp does not exceed 20pp threshold — MITIGANT APPLIES, downgrade to FORRe-evaluating: 5-year gap is -3.4pp which does NOT exceed the 20pp threshold, so the 5-year mitigant fires and vote is downgraded to FOR

The 3-year TSR trigger fires (MTD underperformed its compensation peer group by 21.7 percentage points, exceeding the 20pp threshold for negative absolute returns), but the 5-year record shows MTD trailed peers by only 3.4 percentage points — well below the 20pp threshold — so the policy's 5-year mitigant applies and the vote is downgraded to FOR; Diggelmann joined in August 2022, meaning his tenure only partially overlaps the underperformance period, which further supports a FOR vote.

For Analysis

✓ FOR
Domitille Doat-Le Bigot

Director joined February 2020 and has relevant digital and cybersecurity expertise; the 3-year TSR trigger fires but the 5-year mitigant applies (5-year peer gap of only -3.4pp is well below the 20pp threshold), so no AGAINST vote is warranted.

✓ FOR
Elisha W. Finney

Director has served since November 2017 and chairs the Audit Committee with strong CFO-level financial expertise; the 3-year TSR trigger fires but the 5-year mitigant applies (5-year peer gap of only -3.4pp is well below the 20pp threshold), so no AGAINST vote is warranted.

✓ FOR
Pablo Perversi

Director joined November 2025, well within the 24-month new-director exemption, and is therefore fully exempt from the TSR underperformance trigger.

✓ FOR
Thomas P. Salice

Long-tenured director (since 1996) with deep financial and analytical instruments industry expertise; the 3-year TSR trigger fires but the 5-year mitigant applies (5-year peer gap of only -3.4pp is well below the 20pp threshold), so no AGAINST vote is warranted.

✓ FOR
Brian Shepherd

Director joined July 2024, within the 24-month new-director exemption window, and is therefore fully exempt from the TSR underperformance trigger.

✓ FOR
Michael J. Tokich

Director joined February 2026, well within the 24-month new-director exemption, and is therefore fully exempt from the TSR underperformance trigger.

✓ FOR
Wolfgang Wienand

Director joined November 2023, within the 24-month new-director exemption window, and is therefore fully exempt from the TSR underperformance trigger.

✓ FOR
Ingrid Zhang

Director joined February 2023; her tenure of approximately 3 years overlaps the underperformance period, but the 5-year mitigant applies (5-year peer gap of only -3.4pp is well below the 20pp threshold), so no AGAINST vote is warranted.

The 3-year TSR trigger fires for all directors with sufficient tenure (MTD trailed its compensation peer group by 21.7 percentage points over three years, exceeding the 20pp threshold applicable to companies with negative absolute TSR), but the policy's 5-year mitigant applies across the board because MTD's 5-year underperformance versus peers is only 3.4 percentage points — far below the 20pp threshold. As a result, all nine directors receive a FOR vote. Three directors (Perversi, Shepherd, Tokich, Wienand) are additionally exempt under the 24-month new-director rule. The board is 100% independent with a strong skills matrix and sound governance practices.

Say on Pay

✓ FOR

CEO

Patrick Kaltenbach

Total Comp

$6,741,212

Prior Support

86%%

CEO total compensation of $6,741,212 is within a reasonable range for the CEO of a $24.6 billion healthcare instrumentation company, and the prior year Say on Pay vote received strong 86% support — well above the 70% threshold that would require corrective action. The pay program is heavily weighted toward variable and performance-based pay (base salary of $1,146,000 represents roughly 17% of total compensation, well below the 40% fixed-pay cap), and the long-term incentive mix includes performance stock awards tied to relative total shareholder return versus the S&P 500 Healthcare and Industrials indices, stock options that only create value if the stock price rises, and restricted stock units. Although recent performance share awards have vested at or near zero percent due to TSR underperformance — demonstrating that the pay-for-performance mechanism is actually working as intended — the overall incentive structure is sound and does not warrant a negative vote.

Auditor Ratification

✓ FOR

Auditor

PricewaterhouseCoopers LLP

Tenure

N/A

Audit Fees

$4,556,550

Non-Audit Fees

$507,400

Non-audit fees (audit-related fees of $53,100 plus tax fees of $452,300 plus other fees of $2,000, totaling $507,400) represent approximately 11% of audit fees of $4,556,550, well below the 50% threshold that would raise independence concerns; PwC is a Big 4 firm appropriate for a $24.6 billion market cap company; auditor tenure is not disclosed in the proxy so the tenure trigger cannot fire per policy, and no material restatements are noted.

Overall Assessment

The 2026 Mettler-Toledo annual meeting presents three standard proposals: election of nine independent directors, ratification of PwC as auditor, and an advisory vote on executive compensation. All nine directors receive a FOR vote because although the 3-year TSR trigger fires, the 5-year mitigant applies (MTD's 5-year underperformance vs. peers is only 3.4 percentage points, below the 20pp policy threshold), the auditor passes all fee ratio and adequacy tests, and the executive compensation program is predominantly performance-based with strong prior shareholder support.

Filing date: March 18, 2026·Policy v1.2·high confidence

Compensation Peer Group

16 companies disclosed in 2026 proxy filing

AAgilent Technologies
AMEAMETEK
BIOBio-Rad Laboratories
BRKRBruker Corp.
FTVFortive Corp.
HOLXHologic
IEXIDEX Corp.
ISRGIntuitive Surgical
NDSNNordson Corporation
RMDResMed
RVTYRevvity
ROKRockwell Automation
TDYTeledyne Technologies
TFXTeleflex
WATWaters Corp.
XYLXylem